Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

MacroChem reports results of safety trials with Topiglan

Aug. 6, 1999

Women First to market Fournier's estradiol patch in U.S.

Aug. 6, 1999

INSERM describes TPP II inhibitors and their use in treating eating disorders, obesity

Aug. 5, 1999

SB team identifies bone resorption inhibitors selective for mammalian osteoclasts

Aug. 5, 1999

First launch for bile acid-sequestering agent colestimide

Aug. 5, 1999

GAD65 peptides prevent diabetes in mouse model

Aug. 5, 1999

Novo Nordisk synthesizes potassium channel modulators for endocrine diseases

Aug. 4, 1999

Unigene awarded U.S. patent for oral calcitonin product

Aug. 4, 1999

GelTex seeks FDA approval of Cholestagel

Aug. 3, 1999

Novel MTP inhibitors in early development at Japan Tobacco

Aug. 3, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest
BioWorld
A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
Pleased to own ya, Kelonia: Lilly’s $7B CAR T deal
BioWorld
The already-thriving CAR T space took another big stride forward as Eli Lilly and Co. disclosed its plan to acquire Boston-based Kelonia Therapeutics Inc. for as...